These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Chronopharmacology for deoxyspergualin: toxicity and efficacy in the rat. Uchida H; Kobayashi E; Matsuda K; Mizuta K; Sugimoto K; Kawarasaki H; Hashizume K; Fujimura A Transplantation; 1999 May; 67(9):1269-74. PubMed ID: 10342320 [TBL] [Abstract][Full Text] [Related]
46. Xanthines: ideal immunosuppressants for combination with cyclosporine? Lin Y; Segers C; Mikhalsky D; Schönharting M; Waer M Transplant Proc; 1996 Dec; 28(6):3102. PubMed ID: 8962202 [No Abstract] [Full Text] [Related]
47. A new immunosuppressive agent, 15-deoxyspergualin, in dog renal allografting. Amemiya H; Suzuki S; Niiya S; Fukao K; Yamanaka N; Ito J Transplant Proc; 1989 Jun; 21(3):3468-70. PubMed ID: 2662490 [No Abstract] [Full Text] [Related]
48. Immunosuppressive effects of FK 506 and 15-deoxyspergualin in rat lung transplantation. Katayama Y; Takao M; Onoda K; Hiraiwa T; Yada I; Namikawa S; Kusagawa M Transplant Proc; 1991 Feb; 23(1 Pt 1):349-53. PubMed ID: 1703690 [No Abstract] [Full Text] [Related]
49. Immunosuppressive effects of ursodeoxycholic acid in heart-allografted rats. Bährle S; Szabó G; Dengler TJ; Zimmermann R; Hagl S; Kübler W Transplant Proc; 1998 May; 30(3):864-5. PubMed ID: 9595128 [No Abstract] [Full Text] [Related]
50. 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo. Yuh DD; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):535-9. PubMed ID: 1990605 [No Abstract] [Full Text] [Related]
51. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Wang J; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655 [No Abstract] [Full Text] [Related]
52. C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. Baraldo M; Francesconi A; Barbone F; Tursi V; Livi U; Furlanut M Transplant Proc; 2002 Dec; 34(8):3246-8. PubMed ID: 12493435 [No Abstract] [Full Text] [Related]
53. Effects of combined therapy with prostaglandin E1 and cyclosporine A on rat heart allograft survival. Ozawa T; Kamada N; Ashizawa T; Aoki T; Koyanagi Y; Kimura K Transplant Proc; 1991 Aug; 23(4):2213-4. PubMed ID: 1871850 [No Abstract] [Full Text] [Related]
54. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945 [No Abstract] [Full Text] [Related]
55. 15-Deoxyspergualin in experimental transplant models: a review. Kaufman DB Transplant Proc; 1996 Apr; 28(2):868-70. PubMed ID: 8623440 [No Abstract] [Full Text] [Related]
56. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
57. Effect of FK 506 and cyclosporine on heart allograft survival in rats. Goto S; Stepkowski SM; Kahan BD Transplant Proc; 1991 Feb; 23(1 Pt 1):529-30. PubMed ID: 1703700 [No Abstract] [Full Text] [Related]
58. Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model. Flores HC; Leventhal JR; Gruber SA; Figueroa J; Platt JL; Manivel C; Bach FH; Matas AJ; Bolman RM Transplant Proc; 1992 Apr; 24(2):714. PubMed ID: 1566495 [No Abstract] [Full Text] [Related]
59. Effectiveness of combination therapy using cobra venom factor, splenectomy, and deoxyspergualin in guinea pig to rat cardiac xenografts. Hayashi S; Ito M; Yokoyama I; Uchida K; Takagi H Transplant Proc; 1993 Feb; 25(1 Pt 1):405-6. PubMed ID: 8438355 [No Abstract] [Full Text] [Related]
60. Therapy with 15-deoxyspergualin and total lymphoid irradiation blocks xenograft rejection and antibody formation after xenografting. Marchman W; Araneda D; DeMasi R; Taylor D; Carobbi A; Larkin E; Alqaisi M; Thomas F Transplant Proc; 1991 Feb; 23(1 Pt 1):210-1. PubMed ID: 1990515 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]